Dr. Subodh Bhardwaj is a Medical and Scientific Affairs expert and a Senior Scientist with three decades of experience leading research and development of Vaccines and biopharmaceuticals in the pharmaceutical industry.
He has a tenured a diverse range of experience in medical affairs, basic and clinical research and development, clinical trials, Medical and regulatory writing and pharmacovigilance.
He is currently working as Clinical Research Consultant with Inventprise LLC, Washington, a company which develops new Innovative vaccines and diagnostics. He qualified as a physician from India in 1981 and having worked in Internal Medicine- he completed MD Clinical Pharmacology from the prestigious AMU, in India in 1991. He then worked as Medical, regulatory director with the Serum Institute of India from 1993 for 15 years where he conducted more than 30 clinical trials for licensure and prequalification including- MMR, DTPwHB, Hib, DTPwHB HIB, Rubella, Measles Rubella, Onco BCG, HDC Rabies vaccines, Infertility drugs,Somatostatin, Somatropin ( Serono).
He headed the Pharmacovigilance department and was instrumental in jointly working with WHO Biologicals to conduct large scale epidemiological studies with MMR vaccine and investigate Adverse events to vaccines in different countries like India, Egypt, Chile, Russia, Turkey, Sri Lanka. He subsequently worked with Sanofi Pasteur as Director Medical affairs, Regulatory and Public policy from 2008 to 2011 where he licensed Pentaxim, Menactra, Panenza, and ImovaxPolio vaccines following Phase 3 clinical trials. He holds a Diploma in Pharmacovigilance from Sanofi Pasteur, Lyon (2008). He also worked with Surgipharm Uganda from 2013 to 2015 as Director Medical and Portfolio for several reputed companies, parentrals, specialized feeds, oncology, disinfectants, devices for spine operations and affordable medicines for East Africa where he was involved with Drug Control authorities. He is an avid Medical writer with more than 60 publications in peer reviewed journals and recently published a chapter in" Pharmaceutical Medicine and Translational Clinical Research" published by Elsevier in 2018. He is Member of the British Association of Pharmaceutical Physicians (BRAPP) and European society of Pharmacovigilance (ESOP).
He has also worked on Monoclonals for Rabies and consults with reputed global international organizations since 2016 in New York on topics of public health importance. He recently chaired the 11th International Conference and Exhibition on Pharmacovigilance and Drug safety In June 21-22, 2018 at London.